HEADER LIPID BINDING PROTEIN, TRANSPORT PROTEIN09-JAN-14 2MJI TITLE HIFABP_KETOROLAC_COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: FATTY ACID-BINDING PROTEIN, INTESTINAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FATTY ACID-BINDING PROTEIN 2, INTESTINAL-TYPE FATTY ACID- COMPND 5 BINDING PROTEIN, I-FABP; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FABP2, FABPI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET-45B (+) KEYWDS PROTEIN-LIGAND COMPLEX, INTESTINAL FATTY ACID BINDING PROTEIN, HUMAN KEYWDS 2 FABP2, LIPID BINDING PROTEIN, TRANSPORT PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR R.PATIL,A.LAGUERRE,J.WIELENS,S.HEADEY,M.WILLIAMS,B.MOHANTY,C.PORTER, AUTHOR 2 M.SCANLON REVDAT 3 01-MAY-24 2MJI 1 REMARK REVDAT 2 24-DEC-14 2MJI 1 JRNL REVDAT 1 29-OCT-14 2MJI 0 JRNL AUTH R.PATIL,A.LAGUERRE,J.WIELENS,S.J.HEADEY,M.L.WILLIAMS, JRNL AUTH 2 M.L.HUGHES,B.MOHANTY,C.J.PORTER,M.J.SCANLON JRNL TITL CHARACTERIZATION OF TWO DISTINCT MODES OF DRUG BINDING TO JRNL TITL 2 HUMAN INTESTINAL FATTY ACID BINDING PROTEIN. JRNL REF ACS CHEM.BIOL. V. 9 2526 2014 JRNL REFN ISSN 1554-8929 JRNL PMID 25144524 JRNL DOI 10.1021/CB5005178 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN 3.2, CNS REMARK 3 AUTHORS : BRUKER BIOSPIN (TOPSPIN), REMARK 3 BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI, REMARK 3 NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TORSIONAL ANGLE DYNAMICS REMARK 4 REMARK 4 2MJI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000103688. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-13C; U-15N] HIFABP, 10 REMARK 210 MM 5-BENZOYL,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLIC ACID, 50 MM REMARK 210 NACL, 20 MM MES, 90% H2O/10% D2O; 0.5 MM [U-13C; U-15N] HIFABP, REMARK 210 5 MM 5-BENZOYL,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLIC ACID, 50 MM REMARK 210 NACL, 20 MM MES, 90% H2O/10% D2O; 0.25 MM [U-13C; U-15N] HIFABP, REMARK 210 2.5 MM 5-BENZOYL,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLIC ACID, 50 REMARK 210 MM NACL, 20 MM MES, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCACB; 3D CBCA(CO)NH; 3D 1H- REMARK 210 13C NOESY ALIPHATIC; 3D 1H-13C REMARK 210 NOESY AROMATIC; 3D 1H-15N NOESY; REMARK 210 3D HNCO REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.2, NMRPIPE, SPARKY REMARK 210 3.113, VNMRJ, CNS 3, CARA 4, REMARK 210 CYANA 3 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 10 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H TYR A 117 O ALA A 124 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 4 178.60 172.40 REMARK 500 1 ASP A 9 -73.42 -100.84 REMARK 500 1 ASN A 13 16.59 59.60 REMARK 500 1 HIS A 33 -39.15 165.26 REMARK 500 1 ASN A 35 63.81 -119.53 REMARK 500 1 TYR A 70 39.10 -154.57 REMARK 500 1 ASN A 98 30.73 -155.72 REMARK 500 1 GLU A 120 88.19 26.08 REMARK 500 2 ASP A 3 109.75 -59.23 REMARK 500 2 SER A 4 -175.78 177.30 REMARK 500 2 ASP A 9 -75.07 -95.04 REMARK 500 2 HIS A 33 -38.13 160.11 REMARK 500 2 ALA A 54 -88.29 8.40 REMARK 500 2 ARG A 56 -178.35 -64.11 REMARK 500 2 LEU A 64 104.30 -59.35 REMARK 500 2 TYR A 70 51.55 -160.21 REMARK 500 2 THR A 76 -159.90 44.21 REMARK 500 2 ASN A 98 35.85 -171.71 REMARK 500 2 GLU A 120 88.88 39.39 REMARK 500 2 ARG A 126 115.10 -162.01 REMARK 500 3 ASP A 3 101.42 -52.79 REMARK 500 3 SER A 4 -173.52 178.34 REMARK 500 3 ASN A 13 14.59 59.35 REMARK 500 3 ASN A 24 172.08 -53.54 REMARK 500 3 HIS A 33 -73.96 177.70 REMARK 500 3 ASN A 35 61.40 -101.87 REMARK 500 3 VAL A 60 107.63 -162.09 REMARK 500 3 LEU A 64 105.23 -59.22 REMARK 500 3 TYR A 70 58.23 -174.75 REMARK 500 3 ALA A 73 -166.08 -55.72 REMARK 500 3 ASP A 74 -64.50 69.64 REMARK 500 3 GLU A 77 54.75 -161.60 REMARK 500 3 ASN A 98 40.18 178.15 REMARK 500 3 ILE A 108 85.19 -61.30 REMARK 500 3 GLU A 120 88.65 26.51 REMARK 500 4 ASP A 3 109.81 -55.45 REMARK 500 4 SER A 4 179.73 174.71 REMARK 500 4 ASN A 13 16.24 59.20 REMARK 500 4 HIS A 33 -38.68 168.67 REMARK 500 4 GLU A 43 89.99 -168.51 REMARK 500 4 VAL A 60 139.13 -179.59 REMARK 500 4 TYR A 70 42.39 -157.98 REMARK 500 4 ASN A 71 -87.64 -45.10 REMARK 500 4 LEU A 72 87.20 53.74 REMARK 500 4 THR A 76 -44.20 -160.60 REMARK 500 4 GLU A 77 85.30 69.64 REMARK 500 4 ASN A 98 40.71 -178.12 REMARK 500 4 GLU A 120 90.18 28.77 REMARK 500 5 ASP A 3 106.24 -51.13 REMARK 500 5 SER A 4 -177.77 176.71 REMARK 500 REMARK 500 THIS ENTRY HAS 120 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KTR A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19727 RELATED DB: BMRB DBREF 2MJI A 1 131 UNP P12104 FABPI_HUMAN 2 132 SEQRES 1 A 131 ALA PHE ASP SER THR TRP LYS VAL ASP ARG SER GLU ASN SEQRES 2 A 131 TYR ASP LYS PHE MET GLU LYS MET GLY VAL ASN ILE VAL SEQRES 3 A 131 LYS ARG LYS LEU ALA ALA HIS ASP ASN LEU LYS LEU THR SEQRES 4 A 131 ILE THR GLN GLU GLY ASN LYS PHE THR VAL LYS GLU SER SEQRES 5 A 131 SER ALA PHE ARG ASN ILE GLU VAL VAL PHE GLU LEU GLY SEQRES 6 A 131 VAL THR PHE ASN TYR ASN LEU ALA ASP GLY THR GLU LEU SEQRES 7 A 131 ARG GLY THR TRP SER LEU GLU GLY ASN LYS LEU ILE GLY SEQRES 8 A 131 LYS PHE LYS ARG THR ASP ASN GLY ASN GLU LEU ASN THR SEQRES 9 A 131 VAL ARG GLU ILE ILE GLY ASP GLU LEU VAL GLN THR TYR SEQRES 10 A 131 VAL TYR GLU GLY VAL GLU ALA LYS ARG ILE PHE LYS LYS SEQRES 11 A 131 ASP HET KTR A 201 31 HETNAM KTR (1R)-5-BENZOYL-2,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLIC HETNAM 2 KTR ACID HETSYN KTR KETOROLAC FORMUL 2 KTR C15 H13 N O3 HELIX 1 1 ASN A 13 MET A 21 1 9 HELIX 2 2 ASN A 24 ALA A 32 1 9 SHEET 1 A 5 ILE A 58 GLU A 59 0 SHEET 2 A 5 LYS A 50 SER A 52 -1 N GLU A 51 O ILE A 58 SHEET 3 A 5 LYS A 37 GLU A 43 -1 N LYS A 37 O SER A 52 SHEET 4 A 5 LYS A 46 THR A 48 -1 O LYS A 46 N GLU A 43 SHEET 5 A 5 PHE A 62 GLU A 63 -1 O PHE A 62 N PHE A 47 SHEET 1 B 9 ILE A 58 GLU A 59 0 SHEET 2 B 9 LYS A 50 SER A 52 -1 N GLU A 51 O ILE A 58 SHEET 3 B 9 LYS A 37 GLU A 43 -1 N LYS A 37 O SER A 52 SHEET 4 B 9 SER A 4 GLU A 12 -1 N TRP A 6 O LEU A 38 SHEET 5 B 9 VAL A 122 LYS A 130 -1 O LYS A 125 N GLU A 12 SHEET 6 B 9 GLU A 112 TYR A 119 -1 N TYR A 117 O ALA A 124 SHEET 7 B 9 ASN A 100 ILE A 109 -1 N ASN A 103 O VAL A 118 SHEET 8 B 9 LYS A 88 ARG A 95 -1 N LEU A 89 O ARG A 106 SHEET 9 B 9 TRP A 82 GLU A 85 -1 N SER A 83 O ILE A 90 SITE 1 AC1 9 TYR A 14 PHE A 17 MET A 21 LYS A 27 SITE 2 AC1 9 GLU A 51 TYR A 70 THR A 76 PHE A 93 SITE 3 AC1 9 TYR A 117 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1